Archived Abstracts
An Investigation into the Benefits of Non-Pharmacological Therapy Options for Patients Experiencing Neonatal Abstinence Syndrome
Location
Memorial Ballroom, Hall Campus Center
Access Type
Campus Access Only
Entry Number
38
Start Date
4-8-2020 12:00 PM
End Date
4-8-2020 1:15 PM
Department
Nursing
Abstract
Hospitals across the nation have intensive care units dedicated to neonates who are born with a wide variety of issues, with the hope that specialized care will promote healthy growth so the newborn can return home with its family. Unfortunately, the majority of the country is seeing an increase in neonates being born with drugs in their system from their mother’s ingestion during pregnancy. These babies are born with the substances circulating through their own body as a result of the drugs passing from the mother’s system across the placenta into the baby. After the baby is born, they now experiencing withdrawal from the substance since it is no longer being provided to them through the mother. The withdrawal process is similar to adults, although often negatively impacts the baby for both the short and long term future. The traditional method for treating these infants is to administer opioids to stop the withdraw symptoms then slowly wean the baby from medication. Since the incidence of this is increasing, some Neonatal Intensive Care Units (NICUs) have implemented programs and protocols for the withdraw that promote healing and comfort without using medications alone. This has not yet become a widely accepted practice due to lack of funding or space. This review of literature will investigate why these specialized programs are needed and in what ways the program benefits these babies.
Faculty Mentor(s)
Dr. Amanda PribbleDr. Sara HallowellDr. Nancy Cowden
Rights Statement
The right to download or print any portion of this material is granted by the copyright owner only for personal or educational use. The author/creator retains all proprietary rights, including copyright ownership. Any editing, other reproduction or other use of this material by any means requires the express written permission of the copyright owner. Except as provided above, or for any other use that is allowed by fair use (Title 17, §107 U.S.C.), you may not reproduce, republish, post, transmit or distribute any material from this web site in any physical or digital form without the permission of the copyright owner of the material.
An Investigation into the Benefits of Non-Pharmacological Therapy Options for Patients Experiencing Neonatal Abstinence Syndrome
Memorial Ballroom, Hall Campus Center
Hospitals across the nation have intensive care units dedicated to neonates who are born with a wide variety of issues, with the hope that specialized care will promote healthy growth so the newborn can return home with its family. Unfortunately, the majority of the country is seeing an increase in neonates being born with drugs in their system from their mother’s ingestion during pregnancy. These babies are born with the substances circulating through their own body as a result of the drugs passing from the mother’s system across the placenta into the baby. After the baby is born, they now experiencing withdrawal from the substance since it is no longer being provided to them through the mother. The withdrawal process is similar to adults, although often negatively impacts the baby for both the short and long term future. The traditional method for treating these infants is to administer opioids to stop the withdraw symptoms then slowly wean the baby from medication. Since the incidence of this is increasing, some Neonatal Intensive Care Units (NICUs) have implemented programs and protocols for the withdraw that promote healing and comfort without using medications alone. This has not yet become a widely accepted practice due to lack of funding or space. This review of literature will investigate why these specialized programs are needed and in what ways the program benefits these babies.